Organogenesis Holdings Inc
Statements
Cash Flow
Organogenesis Holdings Inc (ORGO) by the numbers: income statement, balance sheet and cash flow, by year or by quarter. In the most recent period (Q2 26), "Operating Cash Flow" came in at -32 million USD. Tick rows to compare them in a chart.
All figures in millions of USD.
Tick rows to compare them in a chart (up to 4)
| Line item | Q3 16 | Q4 16 | Q1 17 | Q2 17 | Q3 17 | Q4 17 | Q1 18 | Q2 18 | Q3 18 | Q4 18 | Q1 19 | Q2 19 | Q3 19 | Q4 19 | Q1 20 | Q2 20 | Q3 20 | Q4 20 | Q1 21 | Q2 21 | Q3 21 | Q4 21 | Q1 22 | Q2 22 | Q3 22 | Q4 22 | Q1 23 | Q2 23 | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 | LTM* |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 0.0 | -0.5 | -0.1 | 0.2 | -0.5 | -0.1 | -0.2 | -0.2 | -0.3 | -60 | -9.6 | -12 | -5.5 | -6.4 | -17 | -9.3 | 8.9 | 23 | -1.3 | 17 | 28 | 18 | 1.4 | 10 | 5.5 | 7.8 | -5.1 | 8.6 | 17 | 11 | -10 | 4.7 | 8.7 | 11 | -20 | -33 | 3.1 | 39 | 21 | -32 | 32 | |
| – | – | – | – | 0.2 | 0.4 | 1.8 | 1.8 | 1.8 | 7.0 | 2.4 | 2.4 | 2.3 | 2.4 | 1.7 | 1.7 | 2.4 | 2.4 | 3.4 | 3.7 | 4.7 | 4.8 | 2.6 | 2.7 | 2.7 | 4.6 | 5.9 | 3.5 | 3.8 | 12 | 6.2 | 4.2 | 4.4 | 6.4 | 6.3 | 4.6 | 7.0 | 7.0 | 12 | 1.6 | 28 | |
| – | 304 | – | – | – | – | – | – | – | 1.1 | 0.2 | 0.2 | 0.2 | 0.2 | 0.2 | 0.5 | 0.5 | 0.5 | 0.7 | 1.0 | 1.0 | 1.1 | 1.3 | 1.7 | 1.7 | 1.9 | 1.9 | 2.3 | 2.4 | 2.4 | 2.4 | 2.6 | 2.7 | 2.9 | 3.4 | 2.5 | 3.1 | 4.3 | 3.6 | 3.1 | 14 | |
| – | – | – | – | 0.1 | 0.7 | 2.5 | 2.5 | 3.6 | 7.4 | 2.5 | 1.2 | 1.2 | 2.0 | 0.7 | 2.7 | 0.9 | 3.2 | 1.8 | 2.5 | 4.0 | -31 | 1.5 | 2.1 | 6.8 | 4.9 | 2.3 | 6.5 | – | – | – | – | – | – | – | – | – | – | – | – | – | |
| 0.0 | -0.4 | -0.3 | -0.2 | 1.6 | 0.4 | -0.1 | -0.6 | -5.2 | -17 | 1.0 | -6.0 | 1.7 | -6.4 | -3.4 | -8.6 | -16 | 0.2 | -19 | -8.8 | 2.8 | -12 | -5.9 | -8.3 | -8.6 | -11 | -12 | -6.6 | 3.0 | -2.7 | -21 | -7.6 | -14 | -6.8 | -21 | -38 | -30 | -44 | 71 | 8.1 | 5.1 | |
| 0.0 | 0.0 | 0.0 | 0.0 | 0.2 | 0.2 | 0.1 | 0.3 | 0.9 | 1.9 | 0.3 | 1.2 | 1.3 | 3.5 | 4.2 | 2.2 | 5.8 | 5.4 | 5.0 | 4.3 | 17 | 5.2 | 6.7 | 6.2 | 10 | 11 | 7.6 | 7.5 | 6.0 | 3.3 | 2.2 | 1.9 | 2.6 | 3.4 | 3.6 | 3.6 | 2.2 | 4.7 | 3.1 | 1.1 | 11 | |
| – | -310 | – | – | -0.2 | -0.2 | -0.1 | -0.3 | -0.9 | -1.9 | -0.3 | -1.2 | -1.3 | -3.5 | -4.2 | -1.9 | -12 | -5.4 | -5.0 | -4.3 | -17 | -5.2 | -6.7 | -6.2 | -10 | -11 | -7.6 | -7.5 | -6.0 | -3.3 | -2.2 | -1.9 | -2.6 | -3.4 | -3.6 | -3.6 | -2.2 | -4.7 | -3.1 | -1.1 | -11 | |
| – | – | – | – | 0.0 | 0.0 | 0.7 | – | – | – | – | – | – | 0.6 | – | – | – | – | – | – | – | – | – | – | – | – | – | 0.0 | – | – | – | – | – | 1.8 | 1.8 | 2.8 | 5.6 | 0.2 | 3.0 | – | – | |
| – | – | – | – | 0.0 | 0.0 | – | – | – | 0.1 | -6.8 | 0.0 | 0.0 | 6.8 | 0.0 | 0.0 | 0.0 | 0.0 | -0.4 | 0.2 | 0.9 | 0.1 | 0.3 | -0.2 | 0.0 | – | -0.3 | 0.0 | 0.0 | 0.3 | – | – | – | -25 | – | – | – | – | – | – | – | |
| – | – | – | – | 0.6 | 1.4 | 3.0 | 9.9 | 2.8 | -21 | 27 | 2.2 | 9.7 | -0.4 | 9.5 | 5.3 | -0.6 | -30 | -0.7 | -0.7 | 2.7 | -0.5 | -0.6 | -0.6 | -0.9 | -1.9 | -0.9 | -1.0 | – | – | – | – | -1.7 | -63 | -0.3 | -0.3 | -0.3 | -0.3 | -9.8 | -0.3 | -11 | |
| 0.1 | 311 | -0.4 | – | 0.5 | 0.1 | 0.2 | 0.2 | 0.2 | 81 | 19 | 2.8 | 9.7 | 47 | 8.2 | 4.9 | -0.8 | 30 | -0.6 | -0.8 | 1.3 | -0.9 | -0.8 | 0.4 | 0.0 | -1.9 | -1.2 | -1.1 | -1.4 | -1.8 | -2.6 | -1.7 | -1.7 | 34 | -2.1 | -0.3 | -10 | -4.8 | -20 | -13 | -48 | |
| 0.1 | 0.9 | -0.6 | -0.2 | -0.2 | 0.0 | 0.0 | 0.0 | -0.1 | 21 | 9.3 | -11 | 3.0 | 37 | -13 | -6.3 | -3.9 | 48 | -6.8 | 12 | 12 | 12 | -6.0 | 4.4 | -4.9 | -4.7 | -14 | 0.1 | 9.3 | 5.5 | -15 | 1.1 | 4.4 | 41 | -26 | -37 | -9.4 | 30 | -2.2 | -45 | -27 | |
| 0.0 | -0.5 | -0.1 | 0.2 | -0.5 | -0.1 | -0.2 | -0.2 | -0.3 | -62 | -9.9 | -13 | -6.7 | -9.9 | -22 | -12 | 3.0 | 18 | -6.3 | 13 | 11 | 13 | -5.3 | 4.0 | -4.9 | -2.9 | -13 | 1.1 | 11 | 7.3 | -12 | 2.9 | 6.1 | 7.6 | -24 | -37 | 0.8 | 35 | 18 | -33 | 21 |
LTM = last twelve months (sum of the four most recent quarters).
Showing the most recent 40 periods — older statements are on file for this stock.
Data as of: September 25, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.